“HOT” stock: Clarity Pharmaceuticals (CU6)
In our “HOT” stock column, Michael Gable, Managing Director of Fairmont Equities, explains why he expect Clarity Pharmaceuticals (CU6) to continue trending higher from here and current levels are a buying opportunity.